ERBB2 and breast cancer: The reasons for successful treatment in this case as follows: Expression of HR (ER 80% +, PR 60% +) and the biological characteristics of the patient’s tumor were better than those with low HR expression, closer to HER2-negative and HR-positive breast cancers.